Adhesive composition, including a mixture of about 1 percent to about 35 percent by weight of chlorinated polymer, about 1 percent to about 35 percent by weight of a nitrile elastomer, a rubber-modified acrylonitrile copolymer, or mixtures thereof, and about 25 percent to about 90 percent by weight
Adhesive composition, including a mixture of about 1 percent to about 35 percent by weight of chlorinated polymer, about 1 percent to about 35 percent by weight of a nitrile elastomer, a rubber-modified acrylonitrile copolymer, or mixtures thereof, and about 25 percent to about 90 percent by weight of an alkyl acrylate or methacrylate monomer.
대표청구항▼
Adhesive composition, including a mixture of about 1 percent to about 35 percent by weight of chlorinated polymer, about 1 percent to about 35 percent by weight of a nitrile elastomer, a rubber-modified acrylonitrile copolymer, or mixtures thereof, and about 25 percent to about 90 percent by weight
Adhesive composition, including a mixture of about 1 percent to about 35 percent by weight of chlorinated polymer, about 1 percent to about 35 percent by weight of a nitrile elastomer, a rubber-modified acrylonitrile copolymer, or mixtures thereof, and about 25 percent to about 90 percent by weight of an alkyl acrylate or methacrylate monomer. in said carcinoma comprises prostrate cancer. 6. A method for the treatment of carcinoma in a human as set forth in claim 1, wherein said carcinoma comprises pancreatic cancer. 7. A method for the treatment of carcinoma in a human as set forth in claim 1, wherein said carcinoma comprises stomach cancer. 8. A method for the treatment of carcinoma in a human as set forth in claim 2, wherein said reacting an ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogens, and a double bond is positioned between carbon three and four with a tosyl chloride or a mesyl chloride to form a tosylate or mesylate of an ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogens, and a double bond is positioned between carbon three and four, and reacting said tosylate or mesylate of an ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogens, and a double bond is positioned between carbon three and four with diazabicyclo-undecene forms an ester of a fatty acid having somewhere in its carbon chain a chain of four carbons with two conjugated double bonds having a purity greater than 70%. 9. A method for the treatment of carcinoma in a human as set forth in claim 2, wherein diazabicyclononene is used in place of said diazabicyclo-undecene. 10. A method for the treatment of carcinoma in a human as set forth in claim 1, wherein said providing a tosylate of an ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogens, and a double bond is positioned between carbon three and four comprises reacting an ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogens, and a double bond is positioned between carbon three and four with p-toluene sulfonic anhydride. 11. A method for the treatment of carcinoma in a human as set forth in claim 1, wherein said providing a tosylate of an ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogens, and a double bond is positioned between carbon three and four comprises reacting an methyl ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogens, and a double bond is positioned between carbon three and four with tolueue sulfonyl chloride. 12. A method for the treatment of carcinoma in a human as set forth in claim 1, wherein said providing a mesylate of an ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogens, and a double bond is positioned between carbon three and four comprises reacting a methyl ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogens, and a double bond is positioned between carbon three and four with mesyl chloride. 13. A method for ameliorating the effects of carcinoma in a human, comprising: (a) providing a purified fatty acid having somewhere in its carbon chain a chain of four carbons with two conjugated double bonds formed by reacting an ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group,
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (13)
Briggs, Paul C., (Meth)acrylate-based compositions.
Lingier Willy F. R. (Beersel BEX) Lanza Emmanuel (Brussels BEX) Bracke William J. I. (Hamme BEX), Process for preparing rubber-modified styrene copolymers by suspension copolymerization.
Fang, Xiaomei; Miebach, Thomas; Simon, David; Seeger, Jordan Philip, UV-IR combination curing system and method of use for wind blade manufacture and repair.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.